Science & Technology
Phase II: Development of Low-Cost, Shelf-Stable Treatment for Tuberculosis
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N93023C00060
Award Ceiling
$1.5M
Award Floor
$1.5M
Close Date
N/A
Total Funding
$1.5M
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N93023C00060
Description
SBIR Phase Phase II award: "Phase II: Development of Low-Cost, Shelf-Stable Treatment for Tuberculosis" awarded to VIA THERAPEUTICS, LLC in AUSTIN, Texas. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $1,468,122. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.